Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Inflammatory Waldenström Macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort

Blood blood.2024025738.

https://doi.org/10.1182/blood.2024025738

Published: 2024

Includes: Supplemental data

Journal Articles

Effect of Daratumumab on Renal Outcome in Newly Diagnosed Multiple Myeloma with Light Chain CAST Nephropathy

Daren Yabi, Pierre-Edouard Debureaux, Zoe van De Wyngaert, Pauline Caillard, Murielle Roussel, Marguerite Vignon, Thomas Chalopin, Nathalie Forgeard, Tristan Vaugeois, Alexis Talbot, Bertrand Arnulf, Camille Cohen, Stephanie Harel

Blood (2024) 144 (Supplement 1): 1980.

https://doi.org/10.1182/blood-2024-207028

Published: 2024

Journal Articles

Inflammatory Waldenström Macroglobulinemia Is Associated with Clonal Hematopoiesis: A Multicentric Cohort

Blood (2024) 144 (Supplement 1): 4343.

https://doi.org/10.1182/blood-2024-193883

Published: 2024

Journal Articles

Prognostic Value of Positron Emission Tomography/Computed Tomography in Multiple Myeloma Patients Treated with Ide-Cel CAR-T Cell Therapy: Preliminary Results of a Real-World IFM Study from the Descar-T Registry (CAR MY PET)

Blood (2024) 144 (Supplement 1): 4765.

https://doi.org/10.1182/blood-2024-206867

Published: 2024

Journal Articles

Immunological Predictive Markers of Response to Idecabtagene Vicleucel Therapy in Multiple Myeloma : A Real-World Experience from St Louis Hospital (France)

Benoit Ferment, Amani Ouedrani, Romain Stammler, William Dartois, Stephanie Harel, Bruno Royer, Nathalie Forgeard, Tristan Vaugeois, Alexis Talbot, Jean-Christophe Bories, Bertrand Arnulf, Sophie Caillat-Zucman

Blood (2024) 144 (Supplement 1): 4760.

https://doi.org/10.1182/blood-2024-203460

Published: 2024

Journal Articles

Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series

Blood (2024) 143 (8): 734–737.

https://doi.org/10.1182/blood.2023022937

Published: 2024

Journal Articles

Carfilzomib-Pomalidomide-Dexamethasone in Anti-CD38 Antibodies and Lenalidomide Relapse/Refractory Multiple Myeloma: A Real Life Monocentric Cohort

Pierre-Edouard Debureaux, Alexis Talbot, Nathalie Forgeard, Dikelele Elessa, Floriane Theves, Bruno Royer, Nathalie Desrayaud, Antoine Citerne, Wendy Cuccuini, Laureen Chat, Bertrand Arnulf, Stephanie Harel

Blood (2023) 142 (Supplement 1): 6626.

https://doi.org/10.1182/blood-2023-178082

Published: 2023

Journal Articles

Ablation of Cullin-5 in Primary Human T Cells Improves Tumor Killing and Persistence in BCMA-Targeting CAR-T Cells in a Multiple Myeloma Model

Stefanie Bachl, Alexis Talbot, Carter Ching, Nupura Kale, Zhongmei Li, Morgan Diolaiti, Amy Peixin Chen, Joseph Muldoon, Chang Liu, Thomas Martin, Justin Eyquem, Julia Carnevale

Blood (2023) 142 (Supplement 1): 99.

https://doi.org/10.1182/blood-2023-182565

Published: 2023

Journal Articles

Targeted Integration of a Chimeric Antigen Receptor in Key Selected Loci in Primary Natural Killer Cells

Vincent Allain, Allison Rothrock, William Nyberg, Joseph Muldoon, Angela To, Jing-Yi Chung, Christopher Chang, Alexis Talbot, Justin Eyquem

Blood (2023) 142 (Supplement 1): 4807.

https://doi.org/10.1182/blood-2023-183080

Published: 2023

Journal Articles

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor

Blood (2023) 141 (11): 1308–1315.

https://doi.org/10.1182/blood.2022017863

Published: 2023

Includes: Supplemental data

Journal Articles

Prognosis of Hyperviscosity Syndrome in Newly Diagnosed Multiple Myeloma in Modern-Era Therapy: A Real-Life Monocentric Study

Pierre-Edouard Debureaux, Stephanie Harel, Nathalie Parquet, Virginie Lemiale, Virginie Siguret, Laurie Goubeau, Florence Morin, Bruno Royer, Wendy Cuccuini, Dikelele Elessa, Floriane Theves, Anne Brignier, Elie Azoulay, Bertrand Arnulf, Alexis Talbot

Blood (2022) 140 (Supplement 1): 10046–10047.

https://doi.org/10.1182/blood-2022-156598

Published: 2022

Journal Articles

Integrating Transcriptomics and Proteomics for the Discovery of Novel Antigen Targets on Surface of Malignant Plasma Cells Amenable for Chimeric Antigen Receptor-T (CAR-T) Cell Approach in the Treatment of Patients with Relapsed/Refractory Multiple Myeloma

Alexis Talbot, Solène Weill, Eléonore Fox, Léa Meunier, Guillaume Appé, Camille Marijon, Abdelkader Behdenna, Arun P Wiita, Akpéli Nordor, Justin Eyquem

Blood (2022) 140 (Supplement 1): 7094–7095.

https://doi.org/10.1182/blood-2022-168403

Published: 2022

Journal Articles

A Retrospective Study of 67 Inflammatory Waldenström's Macroglobulinemia

Dikelele Elessa, MD, Stephanie Harel, MD, Alexis Talbot, MD, Marion Malphettes, MD, Catherine Thieblemont, MD PhD, Frederic Davi, MD PhD, Odile Maarek, MD, Bertrand Arnulf, MD PhD, Bruno Royer, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-137592

Published: 2020

Journal Articles

Plasma cell–directed therapies in monoclonal gammopathy–associated scleromyxedema

Blood (2020) 135 (14): 1101–1110.

https://doi.org/10.1182/blood.2019002300

Published: 2020

Includes: Supplemental data

Journal Articles

Efficacy and Safety of a FLAG-Sequential Regimen Followed By Hematopoietic Stem Cell Transplantation for Myelodysplasia or Acute Leukemia in Fanconi Anemia: A Franco-Brazilian Report

Pierre-Edouard Debureaux, Flore Sicre de Fontbrune, Carmem M. S. Bonfim, MD, Jean-Hugues Dalle, MD PhD, Nimrod Buchbinder, MD, Yves Bertrand, MD, Cecile Renard, MD, Edouard Forcade, MD, Juliana Fernandes, MD, Alexis Talbot, MD, Ricardo Pasquini, MD, Jean Soulier, MD PhD, Thierry Leblanc, MD, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD

Blood (2019) 134 (Supplement_1): 2498.

https://doi.org/10.1182/blood-2019-122007

Published: 2019

Journal Articles

Overview of the French Practice: Therapeutic Strategies in Patient's First Relapse or Refractory Non IgM AL Amyloidosis

Camille Villesuzanne, Stephanie Harel, Alexis Talbot, MD, Bruno Royer, MD, Naelle Lombion, Fabien Lebras, MD, Mathilde Nouvier, MD, Arnaud Jaccard, MD PhD, Bertrand Arnulf

Blood (2018) 132 (Supplement 1): 3297.

https://doi.org/10.1182/blood-2018-99-114834

Published: 2018

Journal Articles

Non-Interventional Retrospective Multicenter Study Evaluating Real Word Idelalisib Use in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma Patients Enrolled in the French Early Access Program

Loic Ysebaert, MD PhD, Pierre Feugier, Gilles Andre Salles, MD PhD, Eric Durot, MD, Alexis Talbot, MD, Choquet Sylvain, MD, Denise Glorian Kergaravat, Alastair Simpson, Heribert Ramroth, Tarek Abdelhadi, Corinne Haioun, MD, Xavier Troussard, MD

Blood (2018) 132 (Supplement 1): 5924.

https://doi.org/10.1182/blood-2018-99-110766

Published: 2018

Journal Articles

Implication of the Long Non-Coding RNA Crnde in Multiple Myeloma

Antoine David, MS, Ashley Ohnona, Alexis Talbot, MD, Wendy Cuccuini, Jean-Paul Fermand, MD, Jean Soulier, MDPhD, Bertrand Arnulf, MD PhD, Jean Christophe Bories, PhD, Michele Goodhardt, PhD, David Garrick, PhD

Blood (2017) 130 (Supplement 1): 4357.

https://doi.org/10.1182/blood.V130.Suppl_1.4357.4357

Published: 2017

Journal Articles

Global Genomic Analysis of Newly Diagnosed t(4 ;14) Multiple Myeloma Reveals a Specific Mutational Spectrum and Identifies PKD2 As a Potential Therapeutic Target

Xiu Ly Song, Raphaël Szalat, MD, Alexis Talbot, MD, HaiVu Nguyen, PhD, Mehmet K. Samur, PhD, David Mosen-Ansorena, PhD, Nikhil C. Munshi, MD, Stephane Minvielle, PhD, Herve Avet Loiseau, MD PhD, Wendy Cuccuini, MD PhD, Jean-Paul Fermand, MD, Bertrand Arnulf, MD PhD, Jean-Christophe Bories

Blood (2016) 128 (22): 4462.

https://doi.org/10.1182/blood.V128.22.4462.4462

Published: 2016

Journal Articles

Clinical and Biological Features Of Multiple Myeloma (MM) and Monoclonal Gammopathies In Patients With Human Immunodeficiency Virus (HIV) Infection

Alexis Talbot, MD, Laurence Gérard, MD, Raphael Szalat, MD, David Boutboul, Stephanie Harel, MD, Anne Lazareth, Marion Malphettes, MD, PhD, Bouchra Asli, MD, Lionel Galicier, MD, Claire Fieschi, MD, PhD, Eric Oksenhendler, MD, Jean Paul Fermand, MD, Bertrand Arnulf, MD, PhD

Blood (2013) 122 (21): 5348.

https://doi.org/10.1182/blood.V122.21.5348.5348

Published: 2013

NARROW

Inflammatory Waldenström Macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort

Effect of Daratumumab on Renal Outcome in Newly Diagnosed Multiple Myeloma with Light Chain CAST Nephropathy

Inflammatory Waldenström Macroglobulinemia Is Associated with Clonal Hematopoiesis: A Multicentric Cohort

Prognostic Value of Positron Emission Tomography/Computed Tomography in Multiple Myeloma Patients Treated with Ide-Cel CAR-T Cell Therapy: Preliminary Results of a Real-World IFM Study from the Descar-T Registry (CAR MY PET)

Immunological Predictive Markers of Response to Idecabtagene Vicleucel Therapy in Multiple Myeloma : A Real-World Experience from St Louis Hospital (France)

Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series

Carfilzomib-Pomalidomide-Dexamethasone in Anti-CD38 Antibodies and Lenalidomide Relapse/Refractory Multiple Myeloma: A Real Life Monocentric Cohort

Ablation of Cullin-5 in Primary Human T Cells Improves Tumor Killing and Persistence in BCMA-Targeting CAR-T Cells in a Multiple Myeloma Model

Targeted Integration of a Chimeric Antigen Receptor in Key Selected Loci in Primary Natural Killer Cells

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor

Prognosis of Hyperviscosity Syndrome in Newly Diagnosed Multiple Myeloma in Modern-Era Therapy: A Real-Life Monocentric Study

Integrating Transcriptomics and Proteomics for the Discovery of Novel Antigen Targets on Surface of Malignant Plasma Cells Amenable for Chimeric Antigen Receptor-T (CAR-T) Cell Approach in the Treatment of Patients with Relapsed/Refractory Multiple Myeloma

A Retrospective Study of 67 Inflammatory Waldenström's Macroglobulinemia

Plasma cell–directed therapies in monoclonal gammopathy–associated scleromyxedema

Efficacy and Safety of a FLAG-Sequential Regimen Followed By Hematopoietic Stem Cell Transplantation for Myelodysplasia or Acute Leukemia in Fanconi Anemia: A Franco-Brazilian Report

Overview of the French Practice: Therapeutic Strategies in Patient's First Relapse or Refractory Non IgM AL Amyloidosis

Non-Interventional Retrospective Multicenter Study Evaluating Real Word Idelalisib Use in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma Patients Enrolled in the French Early Access Program

Implication of the Long Non-Coding RNA Crnde in Multiple Myeloma

Global Genomic Analysis of Newly Diagnosed t(4 ;14) Multiple Myeloma Reveals a Specific Mutational Spectrum and Identifies PKD2 As a Potential Therapeutic Target

Clinical and Biological Features Of Multiple Myeloma (MM) and Monoclonal Gammopathies In Patients With Human Immunodeficiency Virus (HIV) Infection

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only